biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The Death of xB3 Is Wildly Exaggerated!

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Jun 21, 2022 6:24pm

182 Views

Post# 34772521

RE:RE:RE:The Death of xB3 Is Wildly Exaggerated!

.....I wish I had lots of free cash to mop up some of these shares we see changing hands today....

You do. I see you are uber negative on that other stock today. If you'd rather have BTI, dump the other one, take the tax loss. There's nothing that says you have to make up losses in the same stock.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario